Dawn Bell

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA.

Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH.

Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany.

Delos Capital LLC (Delos Capital) is a private equity firm founded in 2013 by Mattew Constantino. The firm is headquartered in New York.

Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA.

Sichuan Clover Biopharmaceuticals, Inc is a clinical-stage biotechnology company based in Chengdu, China. Clover Biopharmaceuticals' mission is to leverage their trimer-tag technology and in-house manufacturing capabilities to develop and deliver innovative and affordable medical solutions. The Chinese company is committed to partnering with leading healthcare organizations to advance their breakthrough pipeline programs and deliver them to patients. The company's pipeline includes many vaccine and therapeutic candidates for the treatment of infectious disease, cancer, and autoimmune disease, created using trimer-tag platform technology. The company was founded in 2007 by Peng Liang, and Joshua Liang has been the CEO of the company since 2016.

Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong.

Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ.